Osteoporosis Clinical Trial

About This Study

This clinical trial is evaluating an investigational medication designed to increase bone mineral density and reduce the risk of fractures in patients with osteoporosis. The study aims to determine whether this new treatment can build stronger bones more effectively than current standard therapies.

Osteoporosis causes bones to become weak and brittle, significantly increasing the risk of fractures from falls or even minor stresses. For many patients, especially those who have already experienced a fracture or aren't responding well to current treatments, new options are needed.

Learn more about osteoporosis at Overlake Arthritis →

Who May Qualify?

• Have been diagnosed with osteoporosis (T-score ≤ -2.5)
• Are postmenopausal (women) or over 50 (men)
• Have had a fragility fracture OR are at high risk for fractures
• Are between 50 and 85 years old
• Are willing to attend study visits over approximately 18 months

What Participation Involves

• Screening: DEXA bone density scan, blood tests, medical history review
• Study Visits: Approximately 8-10 visits over 18 months
• Medication: Investigational bone-building therapy
• Monitoring: Periodic bone density scans, blood tests, safety assessments

Compensation

Qualified participants receive compensation for time and travel. All study-related care, including bone density scans, is provided at no cost.

Check Your Eligibility

Answer a few quick questions to see if you may qualify. This screening is completely confidential.